🇺🇸 FDA
Pipeline program

A study in healthy men to test how well different doses of BI 3821001 are tolerated

2007-0001

Phase 1 other active

Quick answer

A study in healthy men to test how well different doses of BI 3821001 are tolerated for Healthy volunteer trial is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim International GmbH
Indication
Healthy volunteer trial
Phase
Phase 1
Modality
other
Status
active

Clinical trials